Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
Clinical Nutrition (Edinburgh, Scotland)|December 6, 2024
Association between the dietary inflammatory index and the risk of hepatocellular carcinoma in a cirrhotic populationMaud Rizk, Cécile Roux-Levy, Brigitte Bernard-Chabert, et al.
Journal of Clinical Gastroenterology|November 2, 2013
Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic responseStuart C Gordon, K Rajender Reddy, Ira M Jacobson, et al.
Journal of Viral Hepatitis|April 20, 2021
Variability in molecular characteristics of Hepatitis E virus quasispecies could modify viral surface properties and transmissionCédric Hartard, Honorine Fenaux, Alexis Gentilhomme, et al.
Acta Diabetologica|December 20, 2013
Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosisJean Michel Petit, Samia Hamza, Fabien Rollot, et al.
Journal of Viral Hepatitis|May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohortVictor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki, et al.
The Journal of Nutritional Biochemistry|July 10, 2020
The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitisZeinab Harb, Valérie Deckert, Aude Marchal Bressenot, et al.
Scientific Reports|November 18, 2016
Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat dietAnaïs Bison, Aude Marchal-Bressenot, Zhen Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2015
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapyPhilippe Sultanik, Vincent Mallet, Sylvie Lagaye, et al.
Pageof 20